Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Exp Mol Pathol. 2009 Sep 8;87(3):195–203. doi: 10.1016/j.yexmp.2009.08.003

Table 2.

The relationship between the development of visual symptoms, the presence of anti-transducin-α autoantibodies and diagnosis of cancer in our cohort of patients

Case # Sex/Age Time of Antibody Testing Onset of Visual Symptoms Onset of Cancer Time of Cancer Diagnosis to Retinopathy Onset Cancer Type
1 F/63 5/2006 2006 1999 7 years breast metastatic small cell carcinoma of
2 F/70 3/2007 1/2007 2007 1 month the lung
3 F/45 5/2004 2003 2002 1 year skin
4 F/48 3/2007 2007 NA melanoma metastatic
5 F/73 3/2007 2005 2005 months skin
6 F/89 4/2006 2006 2005 1 year uterine
14 F/86 3/2006 2005 2006 - 1 year colon
26 M/69 10/2000 2000 NA colon, skin
27 M/54 6/2000 1/2000 1994 6 years skin non-small carcinoma of
28 M/75 9/2006 2006 2002 4 years the lung
29 M/80 2/2007 2007 2004 3 years prostate

NA – not available; Case numbers as in Table 1